Franklin Resources Inc Seelos Therapeutics, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.65 - $278.68 $694 - $297,630	1,068 Added 1.4%	77,106 $79,000
Q2 2022 Aug 11, 2022	SELL	$0.51 - $0.93 $18,619 - $33,953	-36,509 Reduced 32.44%	76,038 $52,000
Q4 2021 Feb 11, 2022	SELL	$1.59 - $2.38 $720 - $1,078	-453 Reduced 0.4%	112,547 $183,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $190,970 - $326,570	113,000 New	113,000 $272,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.